| Xvivo Perfusion | |||
| Rapportdag | 2025-07-11 | ||
| (miljoner kronor) | Q2-25, prognos | Antal estimat | Rapporterat i fjol |
| Försäljning | 224 | 6 | 210 |
| Ebitda | 46,5 | 6 | 51 |
| Ebitda, justerat | 47,1 | 6 | 51 |
| Källa: Modular Finance |
| Period | Rapportdatum | Kursutveckling rapportdag, % |
| Q1-25 | 2025-04-24 | 6,9 |
| Q4-24 | 2025-01-28 | 5,0 |
| Q3-24 | 2024-10-24 | -2,7 |
| Q2-24 | 2024-07-12 | 23,8 |
| Q1-24 | 2024-04-24 | 14,8 |
| Q4-23 | 2024-01-25 | -12,7 |
| Q3-23 | 2023-10-24 | 2,2 |
| Q2-23 | 2023-07-13 | -8,0 |